Pipamperone: Difference between revisions
No edit summary |
No edit summary |
||
Line 51: | Line 51: | ||
}} | }} | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Pipamperone''' is an [[antipsychotic]] [[drug]] (a [[butyrophenone]] derivative) used in the treatment of [[schizophrenia]]. Pipamperone is known to the general public under the marketed brand name Dipiperon. It was discovered at [[Janssen Pharmaceutica]] in 1960. | '''Pipamperone''' is an [[antipsychotic]] [[drug]] (a [[butyrophenone]] derivative) used in the treatment of [[schizophrenia]]. Pipamperone is known to the general public under the marketed brand name Dipiperon. It was discovered at [[Janssen Pharmaceutica]] in 1960. | ||
[[File:Pipamperon.JPG| | [[File:Pipamperon.JPG|none|left|400px]] | ||
==See also== | ==See also== | ||
*[[Piritramide]] | *[[Piritramide]] | ||
Line 72: | Line 66: | ||
[[Category:Amides]] | [[Category:Amides]] | ||
[[Category:Organofluorides]] | [[Category:Organofluorides]] | ||
[[Category:Drug]] | [[Category:Drug]] |
Revision as of 15:53, 9 April 2015
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C21H30FN3O2 |
Molar mass | 375.480 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Pipamperone |
Articles |
---|
Most recent articles on Pipamperone Most cited articles on Pipamperone |
Media |
Powerpoint slides on Pipamperone |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Pipamperone at Clinical Trials.gov Clinical Trials on Pipamperone at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Pipamperone
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Pipamperone Discussion groups on Pipamperone Patient Handouts on Pipamperone Directions to Hospitals Treating Pipamperone Risk calculators and risk factors for Pipamperone
|
Healthcare Provider Resources |
Causes & Risk Factors for Pipamperone |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Pipamperone is an antipsychotic drug (a butyrophenone derivative) used in the treatment of schizophrenia. Pipamperone is known to the general public under the marketed brand name Dipiperon. It was discovered at Janssen Pharmaceutica in 1960.
See also
References
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Articles with changed CASNo identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Piperidines
- Amides
- Organofluorides
- Drug